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Abstract
Introduction: Diabetes is a serious health problem affecting approximately 29.1 million individuals in the United States. Another
86 million have prediabetes. The development and implementation of lifestyle modifications such as physical activity for these
persons are among the most effective methods for prevention and treatment. Objective: The aim of this study was to examine
relationships between glycemic control (HbA1c) and cardiovascular fitness (peak maximal oxygen uptake [VO2 peak] and
ventilatory threshold [VT]) in overweight/obese subjects with and without type 2 diabetes (T2DM). In addition, the influences
of body mass index (BMI) and insulin sensitivity (homeostasis model assessment [HOMA %S]) on the relationship between
glycemic control and cardiovascular fitness were explored. Method: Data were abstracted from a completed study that included
51 overweight or obese subjects with T2DM (n ¼ 18), impaired glucose tolerance (n ¼ 8), or normal glucose tolerance (n ¼ 25).
Relationships between glycemic control (HbA1c) and cardiovascular fitness (VO2 peak and VT) were determined using
correlational analysis and multiple linear regression analyses. Results: A statistically significant relationship was observed
between HbA1c and cardiovascular fitness. However, BMI and HOMA %S did not influence the relationship between glycemic
control and cardiovascular fitness. Discussion: HbA1c contributes to VO2 peak and VT in obese and overweight subjects across
glucose tolerance categories. Significant results were achieved despite the fact that there was a limited range of HbA1c based on
the study inclusion criteria. This finding suggests that even a mild decrease in glycemic control can negatively influence
cardiovascular fitness.
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Diabetes remains a serious metabolic health problem affecting
approximately 29.1 million individuals in the United States
alone (9.3% of the population), 8.1 million of whom remain
undiagnosed (Centers for Disease Control and Prevention
[CDC], 2014). Approximately 86 million individuals have prediabetes, which includes impaired fasting glucose (IFG) and
impaired glucose tolerance (IGT; CDC, 2014). Over the past
32 years, the number of adults with diagnosed diabetes in the
United States nearly quadrupled, from 5.5 to 21.3 million, with
about 1.7 million new cases diagnosed each year. If this trend
continues, as many as one of every three adults in the United
States could develop diabetes by 2050. The global prevalence
of type 2 diabetes mellitus (T2DM) is expected to increase
from 366 million in the year 2011 to 552 million in the year
2030 (International Diabetes Federation, 2015).
Clinical trials have consistently demonstrated that people
with diabetes have diminished cardiovascular fitness (maximal/peak exercise capacity, i.e., VO2 max or peak maximal
oxygen uptake [VO2 peak]) compared to those without diabetes
(Baldi, Aoina, Oxenham, Bagg, & Doughty, 2003; Brandenburg

et al., 1999; O’Connor, Kiely, O’Shea, Green, & Egaña, 2012;
Regensteiner et al., 1998; Solomon et al., 2015; Vanninen, Mustonen, Vainio, Länsimies, & Uusitupa, 1992). Studies have also
demonstrated that patients with diabetes reach anaerobic or ventilatory thresholds (VTs) at lower exercise intensities than those
without diabetes (Bergenstal et al., 2013; O’Connor, Green,
Kiely, O’Shea, & Egaña, 2015). This information is important
as individuals with diabetes may reach peak exercise earlier than
those without diabetes. The cause of this decreased
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cardiovascular fitness is not known, but chronic hyperglycemia
is a possible contributor (Solomon et al., 2015). It is important to
clarify the relationship between glycemic control and cardiovascular fitness because chronic elevations in glucose may alter the
exercise response and affect recommendations for exercise as a
treatment modality.
Researchers have examined the relationship between glycemic control and cardiovascular fitness in several studies using
various measures of glucose control (i.e., oral and intravenous
tolerance, fasting glucose levels, and HbA1c) and cardiovascular fitness (i.e., VO2 max, VO2 peak, VT, and metabolic
equivalents [METs]; Fang, Sharman, Prins, & Marwick,
2005; Regensteiner et al., 1998; Ross, Murthy, Wollak, & Jackson, 2010; Vanninen, Uusitupa, et al., 1992) and have reported
inconsistent results. In one of the earliest studies to evaluate
this relationship, Vanninen, Uusitupa, et al. (1992) observed no
correlations between HbA1c and VT or VO2 peak. Regensteiner
et al. (1998) show that individuals with T2DM who did not
have cardiovascular complications were unable to attain VO2
max levels comparable to controls during a graded exercise
test. Fang, Sharman, Prins, and Marwick (2005) examined
whether HbA1c was a predictor of exercise capacity (METs)
in obese adults with and without T2DM and observed that poor
glycemic (HbA1c) control is correlated with diminished exercise capacity (r ¼ ".22, p ¼ .009).
The purpose of the present study was to examine the relationship between glycemic control (HbA1c) and cardiovascular
fitness (VO2 peak and VT) in overweight and obese subjects
with T2DM, IGT, and normal glucose tolerance (NGT). We
also examined the effect of body mass index (BMI) and insulin
sensitivity (homeostasis model assessment [HOMA %S]) on
the relationship between glycemic control and cardiovascular
fitness. We designed this study to answer the following two
research questions:
Research Question 1: What is the relationship between
glycemic control (HbA1c) and cardiovascular fitness (VO2
peak and VT levels)?
Research Question 2: How do selected personal characteristics (BMI and insulin sensitivity) influence the relationship between glycemic control and cardiovascular fitness?

Method
Design
This cross-sectional study was a secondary analysis of data
collected during the screening phase of a study examining postexercise postprandial metabolism (Quinn et al., 2006). The
purpose of the original study was to investigate the effect of
a single bout of aerobic exercise on postprandial metabolism
and markers of oxidative stress. Postprandial markers of oxidative stress and metabolism were collected for individuals
with NGT, IGT, or T2DM for 24 hr after a 30-min bout of
exercise and compared to the same markers from a nonexercise
day. Participants were separated into glucose tolerance categories, NGT, IGT, and T2DM. A 3-hr oral glucose tolerance
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test was performed using a 75-g glucose load. The order of
exercise versus nonexercise day was randomly controlled, and
the days were separated by 1 month. The required number of
subjects for the multiple linear regression model of VO2 peak
and VT was calculated based on the assumptions of nine predictors, with a .8 power and .05 a levels, and R2 as .3. A total of
46 subjects were recommended for this study.
Variables examined in the present study included cardiovascular fitness (VO2 peak, VT); cardiovascular characteristics
(systolic blood pressure [SBP], diastolic blood pressure [DBP],
baseline heart rate, maximal heart rate, and time on treadmill
during a maximal exercise stress test); HbA1c, fasting plasma
glucose, plasma insulin, and insulin sensitivity and b cell function (HOMA %S and HOMA %ß); demographic characteristics
(age, gender, duration of diabetes, and ethnicity); and anthropometric measurements (weight, height, and BMI).

Participants
To be eligible for this study, potential participants were
required to be (a) overweight/obese (BMI 27"42 kg/m2) with
T2DM and being treated with oral diabetes medications or diet;
an HbA1c, #9.0%; and duration of T2DM #7 years; or (b)
overweight or obese without diabetes. All participants were
required to be 18–55 years of age. The duration of diabetes
was set to less than 7 years to limit the number and severity
of complications resulting from T2DM.
Individuals in the original study were excluded if they had
(a) type 1 diabetes mellitus or insulin-controlled T2DM; (b)
metabolic instability over the previous 3 months (e.g., hospitalization for diabetes-related complication); (c) change in
weight by 3 kg or change in diet or physical activity patterns
over the previous 3 months; (d) current medications that would
interfere with glucose tolerance (e.g., steroids); (e) history of
significant medical illness including liver, renal, cardiovascular, or thromboembolic disease; (f) history of diabetes mellitus
complications for which exercise was contraindicated; (g) history of proliferative retinopathy; (h) history of severe peripheral vascular disease and neuropathy; (i) current pregnancy; (j)
physical disability that would limit their ability to walk on a
treadmill; or (k) inability to comply with the study protocol.

Variables
Dependent variables. The dependent variables we used were
VO2 peak and VT.
VO2 peak. Oxygen consumption (VO2) reflects the volume
of oxygen the body consumes and uses and can be measured
during maximal and submaximal exercise testing (McArdle,
Katch, & Katch, 2016). VO2 max is measured during the latter
part of a maximal exercise stress test, when oxygen consumption increases only slightly in spite of increases in exercise
intensity. It represents the highest VO2 attainable during maximal exercise and the maximal volume of oxygen the body uses
during intense whole-body exercise (McArdle et al., 2016).
VO2 max is considered to be the best indicator of aerobic
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Table 1. Demographic Characteristics and Body Composition by Group.
Normal Glucose Tolerance
Variable
Age (years)
Ethnicity
African American
Caucasian
Hispanic
Gender: Female
Duration of diabetes (years)
Weight (kg)
Height (m)
Body mass index (kg/m2)

Impaired Glucose Tolerance

n (%)

M (SD), Range

n (%)

25 (49.0)

42.8 (10.1), 23.0–55.0

8 (16.0)

13
8
4
17

(25.0)
(16.0)
(8.0)
(33.0)

25 (49.0)
25 (49.0)
25 (49.0)

M (SD), Range

8 (16.0)
8 (16.0)
8 (16.0)

n (%)

M (SD), Range

46.0 (7.1), 34.0–53.0

18 (35.0)

46.9 (6.5), 34.0–55.0

105.6 (12.2), 92.9–130.6
1.73 (0.08), 1.7–1.9
35.4 (3.3), 30.3–40.7

14 (27.0)
1 (2.0)
3 (6.0)
16 (31.0)
18 (35.0)
18 (35.0)
18 (35.0)
18 (35.0)

4.1 (2.3), 0.5–7.0
100.3 (13.7), 75.6–120.2
1.66 (0.08), 1.5–1.8
36.4 (4.4), 28.1–44.1

2 (4.0)
5 (10.0)
1 (2.0)
6 (12.0)
95.5 (15.7), 64.1–124.2
1.67 (0.09), 1.4–1.8
34.2 (3.6), 27.7–41.2

Type 2 Diabetes

Note. M ¼ mean; SD ¼ standard deviation.

capacity or cardiovascular fitness in individuals who do not
have physical or psychological limitations; however, in the
presence of physical or psychological limitations that prevent
an individual from exercising to maximal capacity, VO2 peak
reflects the highest VO2 that the person can attain (McArdle
et al., 2016). VO2 peak is the best indicator of near maximal
cardiovascular fitness or peak exertion. Therefore, we used
VO2 peak in the present study.
VT. The VT corresponds to a disproportionate increase in VE
(minute ventilation) versus VO2 (VE/VO2; McArdle et al.,
2016) and has been validated as a key indicator of submaximal
aerobic performance (Santos & Giannella-Neto, 2004). It can
be represented graphically as the point of nonlinear rise in
carbon dioxide production relative to O2 consumption (Beaver,
Wasserman, & Whipp, 1986). We extracted VT and VO2 peak
from the cardiopulmonary exercise test results obtained during
the treadmill exercise test performed during the screening visit.
Independent variable. Our independent variable was glycemic
control represented by HbA1c. We measured HbA1c with a
Bayer DCA 2000 (Elkhart, IN) using the monoclonal antibody
method (Nathan et al., 2008).
Covariates. Our covariates were body composition, age, gender,
ethnicity, duration of diabetes, and insulin sensitivity.
Body composition. We used BMI as an indicator of body composition. BMI represents the body mass in relation to stature. We
calculated it by dividing weight in kilograms by height in meters
squared (McArdle et al., 2016). BMI ranges are typically categorized into four designations: underweight (<18.5 kg/m2), normal (18.5"24.9 kg/m2), overweight (25"29.9 kg/m2), and obese
($30.0 kg/m2; CDC, 2016). The height (without shoes) was
measured to the nearest whole centimeter and the weight to the
nearest kilogram using a stadiometer.
Age, gender, ethnicity, and duration of diabetes. We obtained
age in years, gender, ethnicity, and duration of diabetes from
the screening data. The duration of diabetes was defined by the
number of years from the date of T2DM diagnosis.

HOMA. We measured insulin sensitivity using HOMA
(Wallace, Levy, & Matthews, 2004), a web-based computer
program developed at the University of Oxford. The program
uses nonlinear solutions to estimate insulin resistance and
secretory characteristics. The program also accounts for variations in both hepatic and peripheral insulin resistance. The
computer model can be used to determine insulin sensitivity
(%S) and ß-cell function (%ß) from paired fasting plasma
glucose and radioimmunoassay insulin, specific insulin, or
C-peptide concentrations across a range of 1–2,200 pmol/L for
insulin and 18–454 mg/dl for glucose.

Procedures
The University of Illinois at Chicago Office of Protection of
Research Subjects granted an exemption for the further analysis of the original database. Previously identified variables (see
Design section) were extracted from the existing data set.

Statistical Analysis
Statistical analyses were conducted using SPSS Version 24.
Basic statistics were generated as the first step of the data
analysis and included correlation analysis and comparisons of
means, including frequencies and standard deviations. Relationships between glycemic control (HbA1c) and cardiovascular fitness (VO2 peak and VT) were determined using multiple
linear regression analyses. Two multiple linear regression analyses were used to determine the moderating effect of BMI,
HOMA %S, gender, age, and ethnicity on the relationship
between HbA1c and cardiovascular fitness for each of the
dependent variables VO2 peak and VT.

Results
Tables 1–3 present demographic, body composition, cardiovascular, and metabolic characteristics of the 51 subjects included
in this study. We separated subjects into glucose tolerance
categories (NGT, IGT, and T2DM). Some subjects did not
complete the screening procedures, resulting in missing data
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Table 2. Cardiovascular Parameters by Group.
Normal Glucose Tolerance

Impaired Glucose Tolerance

Variable

n

M (SD), Range

Screening systolic blood pressure (mm Hg)
Screening diastolic blood pressure (mm Hg)
Heart rate baseline (bpm)
Maximal heart rate (bpm)
Time on treadmill (min)
VO2 peak (ml % kg"1 % min"1)
VO2 (L/min)
VT (ml % kg"1 % min"1)
VT (L)
VT (percentage of actual VO2 peak)

25 127.4 (14.3), 106.0–155.0
25 80.8 (12.7), 62.0–109.0
25 80.8 (10.5), 64.0–100.0
25 175.0 (14.9), 141.0–203.0
25
8.8 (1.5), 6.4–12.0
25 24.9 (5.4), 13.2–35.0a
25
2.4 (0.7), 1.3–3.5
24 17.8 (4.5), 12.2–25.9
24
1.7 (0.5), 1.1–3.0
24 75.4 (13.5), 46.2–99.2

Type 2 Diabetes

n

M (SD), Range

n

8
8
8
8
8
8
8
7
7
7

136.4 (15.6), 113.0–162.0
82.3 (11.3), 65.0–100.0
80.6 (11.8), 63.0–96.0
174.8 (4.3), 170.0–180.0
8.3 (2.2), 5.0–12.0
23.9 (7.9), 14.4–38.4
2.6 (0.9), 1.5–4.2
18.7 (6.4), 10.9–30.1
2.0 (0.8), 1.1–3.3
74.0 (3.5), 70.1–79.0

M (SD), Range

18 132.7 (15.2), 109.0–166.0
18 84.3 (7.7), 70.0–99.0
18 86.8 (9.4), 64.0–98.0
18 173.8 (9.0), 153.0–184.0
18
7.4 (2.4), 2.4–11.5
18 20.0 (6.0), 13.3–35.8a
18
2.1 (0.7), 1.0–3.7
17 15.5 (4.5), 10.2–27.6
17
1.5 (0.5), 0.9–3.2
17 75.5 (9.8) 57.0–91.6

Note. Bpm ¼ beats per minute; VO2 ¼ oxygen uptake; VO2 peak ¼ peak maximal oxygen uptake; VT ¼ ventilatory threshold; M ¼ mean; SD ¼ standard deviation.
a
The difference between mean peak maximal oxygen uptake for the normal glucose tolerance and type 2 diabetes groups was statistically significant at a < .05
according to the Bonferroni procedure.

Table 3. Metabolic Characteristics by Group.
Normal Glucose Tolerance

Impaired Glucose Tolerance

Variable

n

M (SD), Range

n

HbA1c (%)
Insulin secretion (HOMA %ß)
Insulin sensitivity (HOMA %S)
Fasting glucose (mg/dl)

24
24
24
24

5.1 (0.4), 4.3–6.0.0a
154.7 (48.6), 83.7–248.1b
54.9 (20.7), 27.0–95.9d,e
97.0 (20.8), 88.2–105.7f

8
8
8
8

5.5
161.1
34.9
97.7

Type 2 Diabetes

M (SD), Range

n

M (SD), Range

(0.5), 4.9–6.2a
(45.3), 106.9–236.30c
(14.3), 23.3–61.8e
(10.1), 89.3–106.1g

16
17
17
17

7.0 (0.7), 5.7–8.7a
109.5 (49.0), 42.7–225.5b,c
37.0 (14.2), 16.5–71.0d
130.6 (34.6), 112.8–148.4f,g

Note. M ¼ mean; SD ¼ standard deviation.
a
Mean HbA1c for the normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) groups differed significantly from that of the type 2 diabetes (T2DM)
group at a < .01 according to the Bonferroni procedure. bThe difference between mean homeostasis model assessment (HOMA) %ß for the NGT and T2DM
groups was statistically significant at a < .01 according to the Bonferroni procedure. cThe difference between mean HOMA %ß for the IGT and T2DM groups was
statistically significant at a < .05 according to the Bonferroni procedure. dThe difference between mean HOMA %S for the NGT and T2DM groups was statistically
significant at a < .01 according to the Bonferroni procedure. eThe difference between mean HOMA %S for the NGT and IGT groups was statistically significant at
a < .05 according to the Bonferroni procedure. fThe difference between mean fasting glucose (mg/dl) for the NGT and T2DM groups was statistically significant at
a < .01 according to the Bonferroni procedure. gThe difference between mean fasting glucose (mg/dl) for the IGT and T2DM groups was statistically significant
at a < .05 according to the Bonferroni procedure.

for certain variables. Of the total 51 subjects, 48 had data
available for VT and HbA1c and 49 had insulin sensitivity
(HOMA %S) data available.

Sample Characteristics
Demographic characteristics. The majority of subjects were
middle-aged African American women (n ¼ 29, 56%), 14
of whom had T2DM for a short duration (Table 1). Subjects
also included Caucasian (n ¼ 14, 28%) and Hispanic individuals (n ¼ 8, 16%), with a disproportionate number of women
(n ¼ 39).
Body composition characteristics. Body composition measurements, presented in Table 1, included screening weight, screening height, and BMI. The majority of individuals were
overweight or obese by BMI status (27.1"44.1 kg/m2). Despite
differences in glucose tolerance status, the entire group was
fairly homogeneous with respect to BMI, with no significant

between-group differences (NGT, M ¼ 34.2 + 3.6; IGT,
M ¼ 35.4 + 3.3; and T2DM, M ¼36.4 + 4.4).
Cardiovascular characteristics. Cardiovascular variables included
baseline heart rate, SBP and DBP, maximal exercise heart
rate, duration of exercise, peak maximal oxygen uptake
(VO2 peak; ml % kg"1 % min"1), oxygen uptake (L/min), VT
(ml % kg"1 % min"1), and VT (percentage of the actual VO2
peak; Table 2). We observed significant inverse relationships
between baseline (resting) heart rate and both VO 2 peak
(p ¼ .003) and VT (p ¼ .006). In addition, there were significant positive relationships between time on treadmill and
VO2 peak and VT (p < .001, p ¼ .019, respectively). There
was a significant difference in VO2 peak between subjects
with NGT and T2DM (p > .05), with those with T2DM having
a significantly lower VO2 peak.
Metabolic characteristics. Metabolic variables included HbA1c,
HOMA %ß, and HOMA %S (Table 3). As expected, we
observed a significantly lower HbA1c level in subjects with
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Table 4. Relationships Between Glycemic Control (HbA1c) and
Measures of Cardiovascular Fitness.
HbA1c
Variable

n

B

SE B

ß

p

R2

VO2 peaka
Ventilatory thresholdb

47
44

"2.78
"1.71

.84
.69

".44
".34

.002
.017

.19
.13

Note. VO2 peak ¼ peak maximal oxygen uptake; SE ¼ standard error.
a
F(1, 46) ¼ 10.86. bF(1, 43) ¼ 6.20.

NGT and IGT compared to those with T2DM (p < .01). HOMA
%ß was significantly greater in those with both NGT and IGT
than in those with T2DM (p < .01 and p < .05, respectively).
HOMA %S was significantly reduced in subjects with IGT and
T2DM compared to those with NGT (p < .05 and p < .01,
respectively). As expected, we observed significantly lower
fasting glucose levels in subjects with NGT and IGT compared
to those with T2DM (p < .01 and p < .05, respectively).

Relationship Between Glycemic Control (HbA1c) and
Cardiovascular Fitness (VO2 Peak and VT Levels)
The first research question aimed to determine the linear relationship between glycemic control (HbA1c) and cardiovascular
fitness (VO2 peak and VT levels). We determined these relationships using multiple regression analyses. As presented in
Table 4, HbA1c explained 19% of the variance in VO2 peak
(p ¼ .002) and 13% of the variance in VT (p ¼ .017).

Influence of Body Composition and Insulin Sensitivity on
the Relationship Between Glycemic Control and
Cardiovascular Fitness
The second research question aimed to determine how
selected personal characteristics (BMI and HOMA %S) influenced the relationship between glycemic control and cardiovascular fitness. We used multiple linear regression analyses
to demonstrate the effects of BMI and HOMA %S on the
relationship between HbA1c and the dependent variables
VO2 peak and VT. The interactions between HbA1c and BMI
and HOMA %S were not significant for the variables VO2
peak or VT. BMI and HOMA %S did not significantly change
the relationships between HbA1c and VO2 peak and VT. Age
(p ¼ .005) and gender (p < .001), however, were significant
predictors of VO2 peak (Table 5), and gender (p ¼ .005)
and ethnicity (p ¼ .001) were significant predictors of VT
(Table 6). Of the three ethnic groups represented in this study,
Caucasians had the highest overall VO2 peak levels, Hispanics had the highest VT levels, and African Americans had the
lowest VO2 peak and VT levels.

Discussion
The most important outcome from the present study, and the
answer to our first research question, is that HbA1c contributed

Table 5. Multiple Linear Regression Model of VO2 Peak.
Variable
Age
Gender
Ethnicity
African
American
Caucasian
HbA1c (%)
HOMA %S
BMI
HbA1c % BMI
HbA1c % HOMA
%S

B

SE B

t

p

95% CI

"0.223 0.075 2.617 .013
["3.75, "0.070]
"7.223 1.414 "5.108 .000 ["10.086, "4.361]
"3.151 1.652 "1.098 .064
"1.095
"8.641
"0.159
"1.635
0.186
0.025

1.874
7.154
0.185
1.095
0.182
0.033

"0.584
"1.208
"0.860
"1.494
1.023
0.754

.563
.235
.395
.144
.313
.455

["6.495, 0.192]
["4.889,
["23.124,
["0.534,
["3.852,
["0.182,
["0.042,

2.699]
5.842]
0.216]
0.581]
0.555]
0.093]

Note. n ¼ 48. F(9, 38) ¼ 9.337, p < .001. BMI ¼ body mass index; HbA1c ¼
measure of glycemic control; HOMA %S ¼ homeostasis model assessment,
insulin sensitivity; VO2 peak ¼ peak maximal oxygen uptake; SE ¼ standard
error; CI ¼ confidence interval.

Table 6. Multiple Linear Regression Model of Ventilatory Threshold.
Variable
Age
Gender
Ethnicity
African
American
Caucasian
HbA1c (%)
HOMA %S
BMI
HbA1c % BMI
HbA1c % HOMA
%S

B

SE B

t

p

95% CI

"0.018 0.076 "0.243 .810 ["0.172, 0.135]
"3.964 1.338 "2.962 .005 ["6.681, "1.248]
"5.968 1.556 "3.835 .001 ["9.126, "2.809]
"1.532
"6.983
"1.08
"1.139
0.163
0.017

1.753
6.660
0.173
1.022
0.170
0.031

"0.874
"1.048
"0.624
"1.115
0.960
0.544

.388 ["5.092, 2.027]
.302 ["20.503, 6.538]
.537 ["0.459, 0.243]
.272 ["3.213, 0.935]
.344 ["0.182, 0.508]
.590 ["0.407, 0.081]

Note. n ¼ 48. F(9, 38) ¼ 4.904, p < .001. BMI ¼ body mass index; HbA1c¼
measure of glycemic control; HOMA %S ¼ homeostasis model assessment,
insulin sensitivity; VO2 peak ¼ peak maximal oxygen uptake; SE ¼ standard
error; CI ¼ confidence interval.

to VO2 peak and VT in obese and overweight subjects across
glucose tolerance categories. The magnitudes of the effects of
HbA1c on VO2 peak and VT were small, however, possibly
because the HbA1c required for study inclusion was #9.0%.
The sample comprised 51 participants, mostly overweight or
obese, middle-aged, African American women, whom we
grouped into glucose tolerance classifications (NGT, IGT, and
T2DM) based on oral glucose tolerance testing. Despite differences in glucose tolerance status, the group was fairly homogeneous with respect to BMI. Only 9.0% (n ¼ 6) had BMI
values less than 30 kg/m2, and 13.7% (n ¼ 8) had values greater
than 40 kg/m2.
There was a wide range of VO2 peak among the study subjects; however, the mean VO2 peak was in the lower physical
fitness range based on gender and age (McArdle et al., 2016).
The VO2 peak of the T2DM group was significantly lower than
that of the NGT group; a finding that previous researchers had
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also noted (Regensteiner et al., 1998). Solomon et al. (2015)
demonstrated similar findings in subjects with varying degrees
of glucose tolerance, observing lower VO 2 max and a
shorter walking time in patients with T2DM compared to controls. Regensteiner et al. (1998) observed a significantly lower
VO2 at submaximal workloads in patients with T2DM compared to controls. Impaired oxygen delivery and a reduction in
cardiac output most likely contribute to decreased maximal
exercise performance in persons with T2DM (Regensteiner
et al., 1998). Likewise, abnormal oxygen uptake during submaximal exercise most likely contributes to limitations in exercise intensity and endurance in these subjects.
Our second research question addressed the influence of the
personal characteristics of BMI and insulin sensitivity on the
relationship between glycemic control and cardiovascular fitness. Using multiple linear regression, we found that neither
BMI nor HOMA %S influenced the relationship between glycemic control and cardiovascular fitness.

Implications
Exercise is a recommended treatment modality for overweight and obese individuals with and without T2DM.
Research demonstrates, however, that cardiovascular fitness
may decrease as glycemic control worsens. A thorough understanding of the relationship between glycemic control and
cardiovascular fitness is important for improving clinicians’
ability to make appropriate treatment recommendations and
exercise prescriptions in overweight and obese adults across
the spectrum of glucose tolerance. In the present study, this
relationship is most apparent in the magnitude of the difference in the VO2 peak (ml % kg"1 % min"1) between patients
with T2DM compared to subjects with NGT and IGT. These
findings demonstrate a relationship between HbA1c and cardiovascular fitness, which is consistent with findings from
several other studies that have used different measurements
of glucose dynamics (Fang et al., 2005; Regensteiner et al.,
1998; Solomon et al., 2015; Vanninen, Uusitupa, et al., 1992).
The most important implication of the present analysis is that
improvements in glycemic control may contribute to
improved cardiovascular fitness and possibly exercise endurance. The identification of more specific changes in glycemic
control and the effects on cardiovascular fitness will allow for
further refinement of interventions to prevent the development the complications that result from diabetes.

Limitations
Sample size and homogeneity of the subjects decreased the
power and likelihood of detecting differences in the outcomes
in the present study. As a result, our ability to generalize these
findings to overweight and obese subjects with T2DM is limited, which indicates the need for additional studies with similar hypotheses. Also, this study was a secondary data analysis,
and a limitation of any secondary data analysis is missing data.
In particular, the group of subjects with IGT was small. This
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group was not included in the initial enrollment criteria and
emerged as a metabolic category during screening as a result of
baseline laboratory measurements. To make statistical comparisons between subjects based on glucose tolerance status more
widely generalizable, more subjects should be included in each
group. Therefore, we recommend a larger sample size for
future research.

Conclusions
Our findings in the present study demonstrated that glycemic
control, as measured by HbA1c, contributed to cardiovascular
fitness in obese and overweight subjects. The relationship
observed was weak, however, as the range of the HbA1c in
this study was limited based on the inclusion criteria. In spite of
the fact that subjects in this small study had relatively wellcontrolled glycemia, we still observed significant relationships
between HbA1c and VO2 peak and VT. Neither insulin sensitivity nor BMI significantly affected these relationships.
These findings support the hypothesis that cardiovascular
fitness is, in part, determined by glycemic control and that the
ability of individuals to achieve cardiovascular fitness may
decrease as glycemic control worsens. Based on these outcomes, it is possible that even mildly elevated HbA1c levels
may contribute to decreased cardiovascular fitness. Additional
studies with similar hypotheses and a larger sample size are
needed to confirm this hypothesis.
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